Literature DB >> 15625851

Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5.

P H Naylor1, H Sheppard, G B Thurman, A L Goldstein.   

Abstract

Using a radioimmunoassay (RIA) for the determination of adenosine 3'5' cyclic monophosphate (cAMP) and an acetylation-RIA procedure to measure guanosine 3'5' cyclic monophosphate (cGMP), we observed that cGMP levels, but not cAMP levels, were significantly elevated in murine thymocytes which had been incubated with preparations containing the thymic hormone, thymosin. Stimulation of intracellular cGMP levels was seen as early as 1 minute after incubation with thymosin fraction 5 and was maximal at approximately 10 minutes. Dose response studies indicated an optimum stimulation of cGMP with a thymosin concentration of 100 microg/ml. A control spleen fraction prepared by an identical procedure as fraction 5 did not affect the levels of either cyclic nucleotide.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 15625851     DOI: 10.1016/0006-291x(76)90198-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Proteins contained in thymus factor X bind to the surface of rat thymocytes.

Authors:  R Brelińska
Journal:  Histochemistry       Date:  1979-10

2.  Immunotherapy of cancer with thymosin.

Authors:  J L Rossio; A L Goldstein
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Effect of catecholamines on lymphopoiesis in fetal mouse thymic explants.

Authors:  U Singh
Journal:  J Anat       Date:  1979-09       Impact factor: 2.610

4.  [Comparative study of the effect of thymosin and supernatant from epithelial thymic cells on antibody production (author's transl)].

Authors:  P Deschaux; R Fontanges; A Goldstein
Journal:  Experientia       Date:  1979-05-15

5.  Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes.

Authors:  I L Sargent; M R Salaman; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.